日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1

利用一种靶向 IFNγ 依赖性 PD-L1 的新型高通量筛选方法，鉴定出 Dinaciclib 和 Ganetespib 为抗炎药物。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1502094
Hagbi-Levi, Shira; Abraham, Michal; Gamaev, Lika; Mishaelian, Inbal; Hay, Ophir; Zorde-Khevalevsky, Elina; Wald, Ori; Wald, Hanna; Olam, Devorah; Weiss, Lola; Peled, Amnon
PD-L1
IFNγ
发表日期：2025
文献求助 收藏

The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition.

致癌性microRNA miR-222促进人类LINE-1逆转录转座

期刊:RNA Biology
影响因子:3.4
doi:10.1080/15476286.2025.2511318
Friehmann Tomer, Abu Mohsen Yamama, Schlesinger Yehuda, Ghantous Lucy, Gamaev Lika, Landau Zenilman Chavah, Harazi Avi, Galun Eithan, Goldenberg Daniel S
肿瘤
Human
发表日期：2025
文献求助 收藏

BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

BKT300：一种靶向细胞分裂蛋白调节因子 1 (PRC1) 通路的新型抗白血病小分子

期刊:
影响因子:
doi:10.21203/rs.3.rs-6017610/v1
Peled Amnon, Abraham Michal, Wald Hanna, Hay Ophir, Hagbi Shira, Gamaev Lika, Monin Jonathan, Borthakur Gautam, Ayoub Edward, Andreeff Michael, Rosenfeld Rakefet, Eizenberg Orly, Aharon Arnon
细胞生物学
白血病
发表日期：2025
文献求助 收藏

CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma

CDC25C蛋白表达与肺腺癌的肿瘤分化和临床预后相关

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11020362
Stern, Esther; Pines, Guy; Lazar, Li Or; Vainer, Gilad W; Beltran, Nitzan; Dodi, Omri; Gamaev, Lika; Hikri Simon, Ofir; Abraham, Michal; Wald, Hanna; Peled, Amnon; Wald, Ori
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏